Report Detail

Request for Sample of this report

Other Global Viral Vectors and Plasmid DNA Manufacturing Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4652629
    • |
  • 25 March, 2026
    • |
  • Global
    • |
  • 120 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Viral Vectors and Plasmid DNA Manufacturing market size was valued at US$ 884 million in 2025 and is forecast to a readjusted size of US$ 5771 million by 2032 with a CAGR of 31.1% during review period.
Viral vectors and plasmid DNA manufacturing represent essential infrastructure in the gene and cell therapy value chain, enabling the delivery and expression of therapeutic genes. Viral vectors—including AAV, adenovirus, and lentivirus—are foundational to CAR-T therapies, gene editing platforms, and vaccine development due to their efficient gene transfer capabilities. Plasmid DNA, as a crucial upstream component, supports viral vector production, mRNA synthesis, and DNA vaccine development. As gene and cell therapies move toward large-scale commercialization, GMP-grade manufacturing capacity of viral vectors and plasmid DNA has become a strategic focal point for biopharma companies, CDMO platforms, and global investors.
As gene and cell therapies gain global regulatory approvals, demand for industrial-scale manufacturing of viral vectors and plasmid DNA is rapidly expanding. Blockbuster CAR-T products, AAV gene therapies, and mRNA vaccines continue to scale up, fueling the need for GMP-compliant platforms, robust quality systems, and high-purity raw materials. CDMO players are becoming the core force in industrial upgrading under the “asset-light” strategies of pharmaceutical companies. Governments worldwide are also promoting bio-manufacturing capacity through strategic funding, infrastructure support, and policy initiatives aimed at localization, modularity, and automation. The industry faces significant technical and operational barriers, including high production costs, lack of standardized processes, and stringent quality control challenges. Key bottlenecks persist in high-purity plasmid preparation and efficient viral vector production, particularly in impurity removal and yield optimization. Regulatory frameworks are evolving rapidly across different regions, requiring manufacturers to navigate diverse GMP compliance requirements and stricter approval thresholds. Additionally, the high concentration of capacity among top-tier CDMOs intensifies competition and pricing pressure, raising the market entry threshold for emerging players. The downstream market is transitioning from academic labs and early-stage biotech firms to commercial-stage biopharmaceutical companies, with order volumes scaling from grams to kilograms. AAV, LNP-mRNA, and CAR-T pipelines heavily rely on customized viral vectors and high-quality plasmids. In rare diseases, oncology, and vaccine development, demand is rising for delivery tools with enhanced expression, reduced immunogenicity, and controlled safety. This is driving the construction of scalable, modular GMP manufacturing systems that can meet precise, application-specific requirements.
This report is a detailed and comprehensive analysis for global Viral Vectors and Plasmid DNA Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Viral Vectors and Plasmid DNA Manufacturing market size and forecasts, in consumption value ($ Million), 2021-2032
Global Viral Vectors and Plasmid DNA Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Viral Vectors and Plasmid DNA Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Viral Vectors and Plasmid DNA Manufacturing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Viral Vectors and Plasmid DNA Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Viral Vectors and Plasmid DNA Manufacturing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Lonza, Azenta Life Sciences, Revvity, VectorBuilder, Takara Bio, GenScript Biotech, Gene Chem, Geno Meditech, PackGene Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Viral Vectors and Plasmid DNA Manufacturing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
AAV
Lentiviruses
Retroviruses
Adenoviruses
DNA Plasmids
Other
Market segment by Application
Pharmaceutical and Biopharmaceutical Companies
Academics and Research Institutes
Market segment by players, this report covers
Thermo Fisher Scientific
Lonza
Azenta Life Sciences
Revvity
VectorBuilder
Takara Bio
GenScript Biotech
Gene Chem
Geno Meditech
PackGene Biotech
VIROVEK
OriGen
Vector BioLabs
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Viral Vectors and Plasmid DNA Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Viral Vectors and Plasmid DNA Manufacturing, with revenue, gross margin, and global market share of Viral Vectors and Plasmid DNA Manufacturing from 2021 to 2026.
Chapter 3, the Viral Vectors and Plasmid DNA Manufacturing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Viral Vectors and Plasmid DNA Manufacturing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Viral Vectors and Plasmid DNA Manufacturing.
Chapter 13, to describe Viral Vectors and Plasmid DNA Manufacturing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Viral Vectors and Plasmid DNA Manufacturing by Type
    • 1.3.1 Overview: Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Viral Vectors and Plasmid DNA Manufacturing Consumption Value Market Share by Type in 2025
    • 1.3.3 AAV
    • 1.3.4 Lentiviruses
    • 1.3.5 Retroviruses
    • 1.3.6 Adenoviruses
    • 1.3.7 DNA Plasmids
    • 1.3.8 Other
  • 1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market by Application
    • 1.4.1 Overview: Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharmaceutical and Biopharmaceutical Companies
    • 1.4.3 Academics and Research Institutes
  • 1.5 Global Viral Vectors and Plasmid DNA Manufacturing Market Size & Forecast
  • 1.6 Global Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast by Region
    • 1.6.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region, (2021-2032)
    • 1.6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospect (2021-2032)
    • 1.6.6 South America Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
    • 2.1.4 Thermo Fisher Scientific Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 Lonza
    • 2.2.1 Lonza Details
    • 2.2.2 Lonza Major Business
    • 2.2.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
    • 2.2.4 Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Lonza Recent Developments and Future Plans
  • 2.3 Azenta Life Sciences
    • 2.3.1 Azenta Life Sciences Details
    • 2.3.2 Azenta Life Sciences Major Business
    • 2.3.3 Azenta Life Sciences Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
    • 2.3.4 Azenta Life Sciences Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Azenta Life Sciences Recent Developments and Future Plans
  • 2.4 Revvity
    • 2.4.1 Revvity Details
    • 2.4.2 Revvity Major Business
    • 2.4.3 Revvity Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
    • 2.4.4 Revvity Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Revvity Recent Developments and Future Plans
  • 2.5 VectorBuilder
    • 2.5.1 VectorBuilder Details
    • 2.5.2 VectorBuilder Major Business
    • 2.5.3 VectorBuilder Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
    • 2.5.4 VectorBuilder Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 VectorBuilder Recent Developments and Future Plans
  • 2.6 Takara Bio
    • 2.6.1 Takara Bio Details
    • 2.6.2 Takara Bio Major Business
    • 2.6.3 Takara Bio Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
    • 2.6.4 Takara Bio Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Takara Bio Recent Developments and Future Plans
  • 2.7 GenScript Biotech
    • 2.7.1 GenScript Biotech Details
    • 2.7.2 GenScript Biotech Major Business
    • 2.7.3 GenScript Biotech Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
    • 2.7.4 GenScript Biotech Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 GenScript Biotech Recent Developments and Future Plans
  • 2.8 Gene Chem
    • 2.8.1 Gene Chem Details
    • 2.8.2 Gene Chem Major Business
    • 2.8.3 Gene Chem Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
    • 2.8.4 Gene Chem Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Gene Chem Recent Developments and Future Plans
  • 2.9 Geno Meditech
    • 2.9.1 Geno Meditech Details
    • 2.9.2 Geno Meditech Major Business
    • 2.9.3 Geno Meditech Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
    • 2.9.4 Geno Meditech Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Geno Meditech Recent Developments and Future Plans
  • 2.10 PackGene Biotech
    • 2.10.1 PackGene Biotech Details
    • 2.10.2 PackGene Biotech Major Business
    • 2.10.3 PackGene Biotech Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
    • 2.10.4 PackGene Biotech Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 PackGene Biotech Recent Developments and Future Plans
  • 2.11 VIROVEK
    • 2.11.1 VIROVEK Details
    • 2.11.2 VIROVEK Major Business
    • 2.11.3 VIROVEK Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
    • 2.11.4 VIROVEK Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 VIROVEK Recent Developments and Future Plans
  • 2.12 OriGen
    • 2.12.1 OriGen Details
    • 2.12.2 OriGen Major Business
    • 2.12.3 OriGen Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
    • 2.12.4 OriGen Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 OriGen Recent Developments and Future Plans
  • 2.13 Vector BioLabs
    • 2.13.1 Vector BioLabs Details
    • 2.13.2 Vector BioLabs Major Business
    • 2.13.3 Vector BioLabs Viral Vectors and Plasmid DNA Manufacturing Product and Solutions
    • 2.13.4 Vector BioLabs Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Vector BioLabs Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Viral Vectors and Plasmid DNA Manufacturing by Company Revenue
    • 3.2.2 Top 3 Viral Vectors and Plasmid DNA Manufacturing Players Market Share in 2025
    • 3.2.3 Top 6 Viral Vectors and Plasmid DNA Manufacturing Players Market Share in 2025
  • 3.3 Viral Vectors and Plasmid DNA Manufacturing Market: Overall Company Footprint Analysis
    • 3.3.1 Viral Vectors and Plasmid DNA Manufacturing Market: Region Footprint
    • 3.3.2 Viral Vectors and Plasmid DNA Manufacturing Market: Company Product Type Footprint
    • 3.3.3 Viral Vectors and Plasmid DNA Manufacturing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Viral Vectors and Plasmid DNA Manufacturing Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Viral Vectors and Plasmid DNA Manufacturing Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Type (2021-2032)
  • 6.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2021-2032)
  • 6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
    • 6.3.1 North America Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Country (2021-2032)
    • 6.3.2 United States Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Type (2021-2032)
  • 7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Application (2021-2032)
  • 7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
    • 7.3.1 Europe Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 7.3.3 France Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region
    • 8.3.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Region (2021-2032)
    • 8.3.2 China Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 8.3.5 India Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Type (2021-2032)
  • 9.2 South America Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Application (2021-2032)
  • 9.3 South America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
    • 9.3.1 South America Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
    • 10.3.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Viral Vectors and Plasmid DNA Manufacturing Market Drivers
  • 11.2 Viral Vectors and Plasmid DNA Manufacturing Market Restraints
  • 11.3 Viral Vectors and Plasmid DNA Manufacturing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Viral Vectors and Plasmid DNA Manufacturing Industry Chain
  • 12.2 Viral Vectors and Plasmid DNA Manufacturing Upstream Analysis
  • 12.3 Viral Vectors and Plasmid DNA Manufacturing Midstream Analysis
  • 12.4 Viral Vectors and Plasmid DNA Manufacturing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Viral Vectors and Plasmid DNA Manufacturing. Industry analysis & Market Report on Viral Vectors and Plasmid DNA Manufacturing is a syndicated market report, published as Global Viral Vectors and Plasmid DNA Manufacturing Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Viral Vectors and Plasmid DNA Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo